Showing results (131-140 of 264) with videos related to

Sort By:
Pageof 27
The Korean Journal of Hematology|April 6, 2012
Relapse pattern and prognostic factors for patients with primary central nervous system lymphomaJeong Eun Kim, Dok Hyun Yoon, Shin Kim, et al.
Journal of Breast Cancer|July 19, 2012
Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancerJeong Eun Kim, Heui June Ahn, Jin-Hee Ahn, et al.
The Korean Journal of Hematology|January 16, 2013
Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cellsTae-Dong Jeong, Chan-Jeoung Park, Hyoeun Shim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled studyYoon-Koo Kang, Sung Sook Lee, Dok Hyun Yoon, et al.
Annals of Laboratory Medicine|August 22, 2019
JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin LymphomaMin Sun Kim, Chan Jeoung Park, Young Uk Cho, et al.
European Journal of Haematology|May 19, 2010
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOPDok Hyun Yoon, Dae Ro Choi, Heui June Ahn, et al.
Annals of Hematology|July 1, 2026
Transcriptomic profiling of an in vivo diffuse large B-cell lymphoma model reveals molecular programs underlying CNS disseminationSo-Jeong Kim, Hyo-Kyung Pak, Hyunji Kim, et al.
Discover Oncology|February 14, 2025
Improving access to chimeric antigen receptor T-cells for refractory or relapsing diffuse large B cell lymphoma therapy in AsiaYa Hwee Tan, Dok Hyun Yoon, Andrew J Davies, et al.
The Korean Journal of Hematology|April 6, 2012
A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomasJeong Eun Kim, Dok Hyun Yoon, Geundoo Jang, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2016
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysisDong-Yeop Shin, Seok Jin Kim, Dok Hyun Yoon, et al.
Pageof 27